Human Host Defense Peptide LL-37 Suppresses TNFα-Mediated Matrix Metalloproteinases MMP9 and MMP13 in Human Bronchial Epithelial Cells

Introduction: TNFα-inducible matrix metalloproteinases play a critical role in the process of airway remodeling in respiratory inflammatory disease including asthma. The cationic host defense peptide LL-37 is elevated in the lungs during airway inflammation. However, the impact of LL-37 on TNFα-driv...

Full description

Bibliographic Details
Published in:	Journal of Innate Immunity
Main Authors:	Anthony Altieri, Courtney Lynn Marshall, Padmanie Ramotar, Dylan Lloyd, Mahadevappa Hemshekhar, Victor Spicer, Anne M. van der Does, Neeloffer Mookherjee
Format:	Article
Language:	English
Published:	Karger Publishers 2024-03-01
Subjects:	cathelicidin ll-37 tnfα host defense peptides inflammation matrix metalloproteinases airway remodeling
Online Access:	https://beta.karger.com/Article/FullText/537775

Similar Items

LL-37 and citrullinated-LL-37 modulate IL-17A/F-mediated responses and selectively suppress Lipocalin-2 in bronchial epithelial cells
by: Anthony Altieri, et al.
Published: (2025-05-01)

Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
by: Fatai Lu, et al.
Published: (2022-08-01)

The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs
by: Kengo eKuroda, et al.
Published: (2015-06-01)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
by: Oriana Simonetti, et al.
Published: (2021-10-01)

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
by: Bapi Pahar, et al.
Published: (2020-09-01)

Colonic epithelial cathelicidin (LL‐37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate
by: Ross J Porter, et al.
Published: (2021-09-01)

Influence of Vitamin D Deficiency on the Level of Salivary cathelicidin LL-37 in relation to Dental Caries Experience: A Case-Control Study
by: Narjes M. Alhelfi, et al.
Published: (2023-04-01)

Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
by: Karol Majewski, et al.
Published: (2018-12-01)

Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications
by: Urszula Wnorowska, et al.
Published: (2020-01-01)

An M protein coiled coil unfurls and exposes its hydrophobic core to capture LL-37
by: Piotr Kolesinski, et al.
Published: (2022-06-01)

Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37
by: Yingxia Zhang, et al.
Published: (2021-11-01)

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
by: Kylen E. Ridyard, et al.
Published: (2021-05-01)

Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
by: Qing Zhang, et al.
Published: (2023-04-01)

Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37
by: Miyoko Tatsuta, et al.
Published: (2019-11-01)

Epithelial-Immune Cell Crosstalk Determines the Activation of Immune Cells In Vitro by the Human Cathelicidin LL-37 at Low Physiological Concentrations
by: Ivan V. Bogdanov, et al.
Published: (2023-08-01)

The role of human β-defensin 2 (HbD-2) and cathelicidin (LL-37) in the local protection of the upper respiratory tract in children with allergic rhinitis and bronchial asthma
by: Yu.K. Bolbot, et al.
Published: (2021-03-01)

Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in <i>Candida auris</i>
by: Irfan A. Rather, et al.
Published: (2022-02-01)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
by: Juanfeng Lao, et al.
Published: (2023-03-01)

Cathelicidin: Insights into Its Impact on Metabolic Syndrome and Chronic Inflammation
by: Alina Delia Popa, et al.
Published: (2024-12-01)

Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients
by: Alexander N. Chernov, et al.
Published: (2024-09-01)

Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma Cells
by: Alexandr N. Chernov, et al.
Published: (2022-08-01)

The Human Antimicrobial Peptides Dermcidin and LL-37 Show Novel Distinct Pathways in Membrane Interactions
by: Kornelius Zeth, et al.
Published: (2017-11-01)

Respiratory tract antimicrobial peptides more effectively killed multiple methicillin-resistant Staphylococcus aureus and nontypeable Haemophilus influenzae isolates after disruption from biofilm residence
by: Nikola Kurbatfinski, et al.
Published: (2025-08-01)

Evaluation of Cathelicidin (LL-37) Serum Levels Among Iraqi Psoriatic Patients and Its Association with Disease Severity and Complications
by: Rasool Moussa Bader Al-asade, et al.
Published: (2025-06-01)

Regulation of LL-37 in Bone and Periodontium Regeneration
by: Zahra Chinipardaz, et al.
Published: (2022-09-01)

Cathelicidin LL37 Promotes Osteogenic Differentiation in vitro and Bone Regeneration in vivo
by: Lunhao Li, et al.
Published: (2021-05-01)

Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis
by: Liam J. O’Neil, et al.
Published: (2021-09-01)

Transforming Cross-Linked Cyclic Dimers of KR-12 into Stable and Potent Antimicrobial Drug Leads
by: Taj Muhammad, et al.
Published: (2023-02-01)

Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury
by: Yihua Bei, et al.
Published: (2019-02-01)

Long-Lasting Stable Expression of Human LL-37 Antimicrobial Peptide in Transgenic Barley Plants
by: Malihe Mirzaee, et al.
Published: (2021-07-01)

Prediction of recurrent currents of tooth decay among pregnant women laboratory method evaluation of antimicrobial activity of immunity oral liquid
by: V. A. Prohodnaja, et al.
Published: (2015-04-01)

A bioavailable form of curcumin suppresses cationic host defence peptides cathelicidin and calprotectin in a murine model of collagen-induced arthritis
by: Mahadevappa Hemshekhar, et al.
Published: (2023-09-01)

Long-Term Administration of LL-37 Can Induce Irreversible Rosacea-like Lesion
by: Chuanxi Zhang, et al.
Published: (2023-03-01)

Vitamin D and LL-37 in Serum and Saliva: Insights into Oral Immunity
by: Sotiria Davidopoulou, et al.
Published: (2025-02-01)

Complexation of fungal extracellular nucleic acids by host LL-37 peptide shapes neutrophil response to Candida albicans biofilm
by: Magdalena Juszczak, et al.
Published: (2024-02-01)

Cord blood antimicrobial peptide LL37 levels in preterm neonates and association with preterm complications
by: Zhuxiao Ren, et al.
Published: (2022-07-01)

The nature of the post-translational modifications of the autoantigen LL37 influences the autoreactive T-helper cell phenotype in psoriasis
by: Roberto Lande, et al.
Published: (2025-04-01)

Cathelicidin in Urinary Tract Diseases: Diagnostic, Prognostic and Therapeutic Potential of an Evolutionary Conserved Antimicrobial Protein
by: Iva Sorić Hosman, et al.
Published: (2024-12-01)

Novel Alligator Cathelicidin As-CATH8 Demonstrates Anti-Infective Activity against Clinically Relevant and Crocodylian Bacterial Pathogens
by: Felix L. Santana, et al.
Published: (2022-11-01)

High Vitamin D Concentrations Restore the Ability to Express LL37 by <i>M. tuberculosis</i>-Infected Human Macrophages
by: María Teresa Herrera, et al.
Published: (2022-02-01)